Compounds > sparfloxacin
Page last updated: 2024-08-24

sparfloxacin and Group A Strep Infection

sparfloxacin has been researched along with Group A Strep Infection in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (83.33)18.2507
2000's0 (0.00)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chiba, K; Egawa, H; Fujita, M; Kataoka, M; Matsumoto, J; Minamida, A; Miyamoto, T; Nishimura, Y; Okada, H; Shibamori, K1
Klesius, PH; Pridgeon, JW1
Blatter, M; Entenza, JM; Glauser, MP; Moreillon, P1
Jones, RN; Pfaller, MA1
Domon, H; Miyazaki, S; Yamaguchi, K; Yoshizumi, S1
Biavasco, F; Mingoia, M; Montanari, MP; Prenna, M; Ripa, S; Varaldo, PE1

Other Studies

6 other study(ies) available for sparfloxacin and Group A Strep Infection

ArticleYear
Synthesis and structure-activity relationships of 5-substituted 6,8-difluoroquinolones, including sparfloxacin, a new quinolone antibacterial agent with improved potency.
    Journal of medicinal chemistry, 1990, Volume: 33, Issue:6

    Topics: 4-Quinolones; Animals; Anti-Infective Agents; Drug Interactions; Fluoroquinolones; Male; Mice; Microbial Sensitivity Tests; Molecular Conformation; Phenylbutyrates; Pseudomonas Infections; Rats; Streptococcal Infections; Structure-Activity Relationship; Theophylline; X-Ray Diffraction

1990
Development of live attenuated Streptococcus agalactiae as potential vaccines by selecting for resistance to sparfloxacin.
    Vaccine, 2013, 05-31, Volume: 31, Issue:24

    Topics: Animals; Antibodies, Bacterial; Cichlids; Drug Resistance, Microbial; Enzyme-Linked Immunosorbent Assay; Fish Diseases; Fluoroquinolones; Streptococcal Infections; Streptococcal Vaccines; Streptococcus agalactiae; Vaccines, Attenuated; Virulence

2013
Parenteral sparfloxacin compared with ceftriaxone in treatment of experimental endocarditis due to penicillin-susceptible and -resistant streptococci.
    Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:12

    Topics: Animals; Anti-Infective Agents; Ceftriaxone; Endocarditis, Bacterial; Female; Fluoroquinolones; Microbial Sensitivity Tests; Penicillin Resistance; Quinolones; Rats; Rats, Wistar; Streptococcal Infections

1994
Comparative antistreptococcal activity of two newer fluoroquinolones, levofloxacin and sparfloxacin.
    Diagnostic microbiology and infectious disease, 1997, Volume: 29, Issue:3

    Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Humans; In Vitro Techniques; Levofloxacin; Ofloxacin; Pneumococcal Infections; Quinolones; Streptococcal Infections; Streptococcus; Streptococcus pneumoniae

1997
In vivo activity of HSR-903, a new fluoroquinolone, against respiratory pathogens.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:4

    Topics: Animals; Anti-Infective Agents; Area Under Curve; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Levofloxacin; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Respiratory Tract Infections; Streptococcal Infections; Streptococcus pneumoniae

1998
Antistaphylococcal and antistreptococcal killing kinetics of ciprofloxacin, ofloxacin, sparfloxacin, and trovafloxacin.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1998, Volume: 17, Issue:11

    Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Quinolones; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pneumoniae; Streptococcus pyogenes

1998